type here...

CATEGORIES

Blood Conditions

LATEST

123Page 3 of 3

TRENDING

EDITORS CHOICE

The Remarkable Research Of CAR T Therapy: B Cell Cancers

William Haseltine, PhD -
The first installment lays the foundation for understanding how CAR T works. This second piece delves into the use of CAR T to treat B cell cancers.

Sudden Death, “Purebloods,” Myocarditis and more

Robert Turner, Founding Editor -
Have we done a peer-review clinical review of COVID-related morbidity/mortality alongside people vaccinated who had serious side effects? Should we?

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Don’t Crystal Ball Patients’ Futures – AI Delivers Accuracy Right Now

Gil Bashe, Medika Life Editor -
Medika Life Talks with Ibex CEO Joseph Mossel on How AI is Changing Pathologists’ Workflow, Output and Professional Satisfaction

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories